Trial Site Detail
Drug: |
Multi-bacteria vaccine (MBV) |
|||
|---|---|---|---|---|
Trial: |
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen. |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Krankenhaus Nordwest |
Principal Investigator: |
Elke Jaeger, MD |
|---|---|
Contact: |
Antje Neumann neumann.antje@khnw.de 069 7601 4161 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Krankenhaus Nordwest Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.